AKIP1 and gastric cancer: Firstly, the median follow‐up duration (34.0 months) was relatively short, and association of AKIP1 expression with prognosis of gastric cancer patients in long term needs further exploration; Secondly, the underlying mechanism of AKIP1 in gastric cancer remained unclear, which was necessary to be investigated in further studies; Thirdly, this was a retrospective study and the AKIP1 expression was restricted to IHC, and thus, further prospective study with other tools (such as qPCR) was needed to validate our results.